43742-1850 NDC - HYDRASTIS CANADENSIS, TARAXACUM OFFICINALE, CIMICIFUGA RACEMOSA, GELSEMIUM SEMPERVIRENS, RHUS TOX, ACETALDEHYDE, CHOLESTERINUM, DOPAMINE HYDROCHLORIDE, EUGENOL, L-PHENYLALANINE, PHENYL ISOTHIOCYANATE, PROGESTERONE, TAURINE, TYRAMINE, ACETYLCHOLINE CHLORIDE, ADRENALINUM, GABA, HISTAMINUM HYDROCHLORICUM, NOREPINEPHRINE (BITARTRATE)

Drug Information

Product NDC: 43742-1850
Proprietary Name:
Non Proprietary Name: Hydrastis Canadensis, Taraxacum Officinale, Cimicifuga Racemosa, Gelsemium Sempervirens, Rhus Tox, Acetaldehyde, Cholesterinum, Dopamine Hydrochloride, Eugenol, L-Phenylalanine, Phenyl Isothiocyanate, Progesterone, Taurine, Tyramine, Acetylcholine Chloride, Adrenalinum, Gaba, Histaminum Hydrochloricum, Norepinephrine (Bitartrate)
Active Ingredient(s): 6 [hp_X]/mL .GAMMA.-AMINOBUTYRIC ACID; 6 [hp_X]/mL ACETALDEHYDE; 6 [hp_X]/mL ACETYLCHOLINE CHLORIDE; 6 [hp_X]/mL BLACK COHOSH; 6 [hp_X]/mL CHOLESTEROL; 6 [hp_X]/mL DOPAMINE HYDROCHLORIDE; 6 [hp_X]/mL EPINEPHRINE; 6 [hp_X]/mL EUGENOL; 6 [hp_X]/mL GELSEMIUM SEMPERVIRENS ROOT; 6 [hp_X]/mL GOLDENSEAL; 6 [hp_X]/mL HISTAMINE DIHYDROCHLORIDE; 6 [hp_X]/mL NOREPINEPHRINE BITARTRATE; 6 [hp_X]/mL PHENYL ISOTHIOCYANATE; 6 [hp_X]/mL PHENYLALANINE; 6 [hp_X]/mL PROGESTERONE; 6 [hp_X]/mL TARAXACUM OFFICINALE; 6 [hp_X]/mL TAURINE; 6 [hp_X]/mL TOXICODENDRON PUBESCENS LEAF; 6 [hp_X]/mL TYRAMINE
Administration Route(s):
Dosage Form(s): LIQUID

Labeler Information

Field Name	Field Value
Labeler Name:	Deseret Biologicals, Inc.
Product Type:	DRUG FOR FURTHER PROCESSING
FDA Application Number:
Marketing Category:	DRUG FOR FURTHER PROCESSING
Start Marketing Date:	10/5/2020
End Marketing Date:	2/1/2026

Package Information

No.	Package Code	Package Description	Billing Unit
1	43742-1850-1	960 mL in 1 BOTTLE, PLASTIC (43742-1850-1)

NDC Record

Field Name	Field Value	Definition
PRODUCT NDC	43742-1850	The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC.
PRODUCT TYPE NAME	DRUG FOR FURTHER PROCESSING	Indicates the type of product, such as Human Prescription Drug or Human Over the Counter Drug. This data element matches the “Document Type” field of the Structured Product Listing.
NON PROPRIETARY NAME	Hydrastis Canadensis, Taraxacum Officinale, Cimicifuga Racemosa, Gelsemium Sempervirens, Rhus Tox, Acetaldehyde, Cholesterinum, Dopamine Hydrochloride, Eugenol, L-Phenylalanine, Phenyl Isothiocyanate, Progesterone, Taurine, Tyramine, Acetylcholine Chloride, Adrenalinum, Gaba, Histaminum Hydrochloricum, Norepinephrine (Bitartrate)	The non-proprietary name is sometimes called the generic name. The generic name usually includes the active ingredient(s) of the product.
DOSAGE FORM NAME	LIQUID	The translation of the dosage form Code submitted by the firm.
START MARKETING DATE	10/5/2020	This is the date that the labeler indicates was the start of its marketing of the drug product.
END MARKETING DATE	2/1/2026	This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached.
MARKETING CATEGORY NAME	DRUG FOR FURTHER PROCESSING	Product types are broken down into several potential Marketing Categories, such as NDA/ANDA/BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources.
LABELER NAME	Deseret Biologicals, Inc.	Name of Company corresponding to the labeler code segment of the Product NDC.
SUBSTANCE NAME	.GAMMA.-AMINOBUTYRIC ACID; ACETALDEHYDE; ACETYLCHOLINE CHLORIDE; BLACK COHOSH; CHOLESTEROL; DOPAMINE HYDROCHLORIDE; EPINEPHRINE; EUGENOL; GELSEMIUM SEMPERVIRENS ROOT; GOLDENSEAL; HISTAMINE DIHYDROCHLORIDE; NOREPINEPHRINE BITARTRATE; PHENYL ISOTHIOCYANATE; PHENYLALANINE; PROGESTERONE; TARAXACUM OFFICINALE; TAURINE; TOXICODENDRON PUBESCENS LEAF; TYRAMINE	An active ingredient is the substance responsible for the medicinal effects of a product specified by the substance's molecular structure or if the molecular structure is not known, defined by an unambiguous definition that identifies the substance. Each active ingredient name is the preferred term of the UNII code submitted.
ACTIVE NUMERATOR STRENGTH	6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6; 6
ACTIVE INGRED UNIT	[hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL; [hp_X]/mL

Drug Information

Labeler Information

Package Information

NDC Record

Download Record